emetine has been researched along with Cancer of Cervix in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boon-Unge, K; Govitrapong, P; Yu, Q; Zhou, A; Zhou, J; Zou, T | 1 |
Collins, JL; Horuchi, T; Kao, MS; Powell, CB | 1 |
Collins, JL; Powell, CB; Scott, JH | 1 |
Collins, JL; Kao, MS; Mutch, DG; Powell, CB | 1 |
Collins, JL; Kao, MS; Massad, LS; Mutch, DG; Powell, CB | 2 |
McClatchie, S; Sambhi, JS | 1 |
Chakrabarti, S; Dube, DK; Roy, SC | 2 |
9 other study(ies) available for emetine and Cancer of Cervix
Article | Year |
---|---|
Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.
Topics: Alternative Splicing; bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cycloheximide; Down-Regulation; Emetine; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Marine Toxins; Okadaic Acid; Oxazoles; Prostatic Neoplasms; Protein Phosphatase 1; Protein Phosphatase 2; Up-Regulation; Uterine Cervical Neoplasms | 2007 |
Interferon alfa activates a lytic mechanism in ovarian and cervical carcinoma cells.
Topics: Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Emetine; Female; Humans; Interferon-alpha; Ovarian Neoplasms; Protein Biosynthesis; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1993 |
Comparison of TNFalpha and TNFbeta cytolytic mechanisms in human ovarian and cervical carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Dactinomycin; Emetine; Female; Humans; Lymphotoxin-alpha; Mice; Ovarian Neoplasms; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1998 |
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
Topics: Animals; Arachidonic Acid; Cell Line; Cell Survival; Drug Resistance; Emetine; Female; Humans; Mice; Neoplasm Proteins; Ovarian Neoplasms; Phospholipases A; Phospholipases A2; Quinacrine; Recombinant Proteins; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1992 |
Inhibition of protein synthesis enhances the lytic effects of tumor necrosis factor alpha and interferon gamma in cell lines derived from gynecological malignancies.
Topics: Cell Line; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Emetine; Female; Genital Neoplasms, Female; Humans; Interferon-gamma; Ovarian Neoplasms; Protein Biosynthesis; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1991 |
Expression of a resistance mechanism in ovarian and cervical carcinoma cells prevents their lysis by gamma-interferon.
Topics: Cell Line; Cell Survival; Dactinomycin; Drug Resistance; Emetine; Female; Humans; Interferon-gamma; Kinetics; Ovarian Neoplasms; Recombinant Proteins; Time Factors; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1990 |
Amoebiasis of the cervix uteri.
Topics: Amebiasis; Biopsy; Diagnosis, Differential; Emetine; Entamoeba histolytica; Female; Humans; Malaysia; Metronidazole; Middle Aged; Uterine Cervical Diseases; Uterine Cervical Neoplasms | 1971 |
Effects of emetine and cycloheximide on mitochondrial protein synthesis in different systems.
Topics: Animals; Cycloheximide; Emetine; Female; Humans; In Vitro Techniques; Mice; Microscopy, Phase-Contrast; Mitochondria; Mitochondria, Liver; Protein Biosynthesis; Uterine Cervical Neoplasms; Uterus | 1972 |
Amino acid incorporation into proteins of human malignant cervical tissue.
Topics: Adenine Nucleotides; Amino Acids; Anti-Bacterial Agents; Carbon Isotopes; Depression, Chemical; Emetine; Female; Humans; Lysine; Microsomes; Mitochondria; Mitomycins; Neoplasm Proteins; Phenylalanine; Polynucleotides; Stimulation, Chemical; Uracil Nucleotides; Uterine Cervical Neoplasms | 1972 |